Skip to main content
Glama

Greynoise

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Despite strong annotations, the description adds substantial behavioral detail: ambiguous names return figi_candidates instead of asserting a match, unresolved identifiers are explicitly listed under unresolved, and LEI/FIGI enrichment degrades gracefully if GLEIF or OpenFIGI is unavailable. It also clarifies the ISIN-to-LEI resolution path and that every identifier is source-labeled.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The primary purpose and usage rule are front-loaded with an explicit 'Use FIRST' directive. The description is dense and lengthy, with a run-on opening paragraph, but nearly every detail serves a real lookup edge case. It is not maximally concise, but the verbosity is largely earned.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a two-parameter resolver with no output schema, the description is remarkably complete. It covers each type's return values, ambiguity handling, unresolved identifier behavior, upstream degradation, and input formatting quirks. Nothing an agent needs to decide whether to call this tool and how to construct the call is obviously missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Even though the schema covers both parameters, the description adds critical semantic guidance beyond the schema. It gives concrete input examples, distinguishes company vs drug formats, and warns against passing full noun phrases like 'NEW YORK ST DORM AUTH revenue bonds' because the FIGI lookup matches instrument names. This materially improves the agent's ability to invoke the tool correctly.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete natural-language examples and clearly states the verb+resource: resolve a user-spoken name to canonical/official identifiers. It explicitly enumerates supported entity types and the identifiers each type returns, making the tool's function unambiguous. This differentiates it from sibling research/profile tools even without naming them.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives an explicit trigger: 'Use FIRST whenever you have a name but need an ID.' It also notes that a single call replaces 2-3 manual lookups, reinforcing when it is appropriate. However, it does not name sibling tools or provide explicit when-not/exclusion conditions, so it stops short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Greynoise toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

ask_pipeworx and ask_pipeworx_beta are explicitly identical right now, creating a true duplicate entry point, and the prediction-market cluster (bet_research, polymarket_arbitrage, polymarket_edges, polymarket_kalshi_spread) all detect mispricings with heavily overlapping descriptions. The detailed docs help, but an agent choosing among these will frequently misselect.

Naming Consistency3/5

The set mixes verb-first names (ask_pipeworx, compare_entities, discover_tools, subscribe) with noun-first names (polymarket_edges, entity_profile, ip_context, recent_changes) and bare verbs (remember, forget) without a unifying convention. Subfamilies are internally consistent (polymarket_*, ask_pipeworx_*, subscribe/unsubscribe), which keeps it readable, but there is no predictable server-wide pattern.

Tool Count2/5

32 tools is well into the too-many band, and several tools duplicate or wrap others: ask_pipeworx_beta is a redundant copy of ask_pipeworx, scan_competitor_ai_presence wraps ai_visibility_check, and bet_research overlaps polymarket_edges/arbitrage. The broad scope justifies a large set, but it would be tighter and clearer around 20-24 tools.

Completeness4/5

For the domain the descriptions actually define (structured-data research, company intelligence, prediction markets, subscriptions, memory), coverage is strong with few dead ends: subscription and memory lifecycles are complete, and research has routing/grounded/deep modes. However, the server is named Greynoise while only ip_context serves that domain, and side tools like generate_llms_txt and scan_dependency sit outside any core workflow.

Resources